SCHEMBL3277223

SCHEMBL3277223

CCOC(=O)c1c(CN)c2ccccc2n1Cc1cccc2ccc(F)cc12

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.53
MEN1 O00255 4/20 0.53
KDM4E B2RXH2 5/20 0.44
ALDH1A1 P00352 2/20 0.44
GAA P10253 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
MAPT P10636 1/20 0.44
ELANE P08246 3/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
F10 P00742 4/20 0.41
MCL1 Q07820 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HPGD P15428 2/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275232 0.94 MEN1 (0.48) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3276972 0.93 KMT2A (0.49) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3282760 0.89 KMT2A (0.52) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3281152 0.87 KMT2A (0.49) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3276470 0.87 MEN1 (0.49) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3276763 0.87 MEN1 (0.49) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3281145 0.86 MEN1 (0.51) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3276217 0.86 MEN1 (0.51) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3276375 0.86 KMT2A (0.73) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL3275053 0.85 MEN1 (0.50) KMT2AMEN1KDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966134-B1 NOVEL FUSED PYRROLE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-12 EP disclosed
US-7696240-B2 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. (US) 2010-04-13 US disclosed
EP-1966134-A1 NOVEL FUSED PYRROLE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
WO-2007068621-A1 NOVEL FUSED PYRROLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-06-21 WO disclosed
US-20070142452-A1 Fused pyrrole derivatives HOFFMANN-LA ROCHE INC. 2007-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070142452-A1 Fused pyrrole derivatives CMA1, PREP, CPA3 KMT2A 3786/4885MEN1 2461/4885KDM4E 2085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.